期刊文献+

奥施康定治疗中晚期胃癌疼痛效果的临床观察 被引量:1

The observation of curative effect of Oxycontin in postoperative pain control on patients suffered from gastric cancer
下载PDF
导出
摘要 目的:评估奥施康定(OxyContin)用于胃癌中晚期患者的镇痛效果,同时观察奥施康定对于胃癌患者生活质量的影响。方法:选择68例胃癌中晚期患者给予奥施康定进行镇痛处理。初始剂量为10mg/12h。在治疗期间,用药剂量根据疼痛缓解程度进行调整,疗程持续15天以上。同时,对服药后的不良反应以及患者生活质量进行观察并记录。结果:奥施康定对中、重度胃癌疼痛的有效率分别为100%和92.0%,能够显著改善患者的睡眠质量和精神状态,同时不良反应较轻。结论:奥施康定能够有效控制中晚期胃癌疼痛,同时明显提高患者的生活质量。 Objective:The aim of this study was to evaluate the efficacy and adverse reactions of OxyContin in the treatment of moderate or severe pain in patients with gastric cancer and to observe any improvement on the cancer patients' quality of life.Methods:Oxycontin was administered at an initial dose of 10 mg every 12h.During the course of treatment, the dosage was adjusted according to the patients' condition until the pain completely disappeared or nearly did so.Results:The overall rate of relief from moderate and severe pain was 100% and 92.0% respectively. Oxycontin had mild adverse reactions and patients' quality of life was markedly improved.Conclusion:Oxycontin is effective in postoperative pain control on patients with gastric cancer. The adverse reactions of Oxycontin are mild, and the drug can significantly improve the quality of life of patients after the surgery.
作者 杨凤明
机构地区 安徽省肿瘤医院
出处 《安徽卫生职业技术学院学报》 2014年第2期28-29,共2页 Journal of Anhui Health Vocational & Technical College
关键词 奥施康定 胃癌 镇痛 Oxycontin Gastric cancer Postoperative analgesia
  • 相关文献

参考文献5

  • 1黄蕾,吴海鹰,刘俊玲,胡晓晔,戴文清,段海波.羟考酮控释片(奥施康定)缓解癌痛及改善肺癌患者生活质量的观察[J].中国疼痛医学杂志,2007,13(2):88-91. 被引量:28
  • 2Ballantyne JC.Chronic pain following treatment for cancer:the role of opioids.The oncologist 2003,8(6):567 -575.
  • 3Gregory D,Johnston R,Pratt G,Watts M,Whatmore,S.The dictionary of human geography.Wiley.com:2009.
  • 4Nielsen CK,Ross FB,Lotfipour S,et al.Oxycodone and morphine have distinctly different pharmacological profiles:radioligand binding and behavioural studies in two rat models of neuropathic pain.Pain 2007,132(3):289 -300.
  • 5Hagen NA,Babul N.Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain.Cancer 1997,79(7):1428-1437.

二级参考文献10

  • 1World Health Organization. Cancer pain relief.World Health Organization, Geneva, 1956.
  • 2Salzman RT, Roberts MS, Wild J, et al. Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form forthe purpose of titrating to stable pain control? J Pain Symptom Manage, 1999,15:271 -279.
  • 3Kalso E. Oxycodone. Pain and Symptom Management, 2005, 29(5 Suppl) :S47 - S56.
  • 4Watson CP, Moulin D, Watt-Watson J, et al.Controlled-Release Oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain, 2003,105 : 71 -78.
  • 5Koizumi W, Toma H, Watanabe K, et al. Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tablets.Jpn J Clin Oncol, 2004,34 : 608 -614.
  • 6Parris WC, Johnson BW Jr, Croghan MK, et al.The use of controlled-release oxycodone for the treatment of chronic cancer pain: a randomized,double-blind study. J Pain Symptom Manage, 1998,16:205 -211.
  • 7Kalso E, Vainio A. Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther, 1990,47:639 - 46.
  • 8Hagen NA, Babul N. Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphonein the treatment of cancer pain. Cancer, 1997, 79 : 1428 - 1437.
  • 9姚嫱,朱思伟,李维廉.美施康定控制癌症疼痛剂量个体化的临床研究[J].中国肿瘤临床,2001,28(6):472-473. 被引量:15
  • 10邓迺封.奥施康定—即控释型盐酸羟考酮[J].疼痛,2002,10(2):24-26. 被引量:8

共引文献27

同被引文献12

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部